| Literature DB >> 26681686 |
J-P Spano1, I Poizot-Martin2, D Costagliola3, F Boué4, O Rosmorduc5, A Lavolé6, S Choquet7, P-E Heudel8, V Leblond9, J Gabarre10, M-A Valantin11, C Solas12, A Guihot13, G Carcelain14, B Autran14, C Katlama11, L Quéro15.
Abstract
Malignancies represent a major cause of morbidity and mortality in human immunodeficiency virus (HIV)-infected patients. The introduction of combined antiretroviral therapy has modified the spectrum of malignancies in HIV infection with a decreased incidence of acquired immunodeficiency syndrome (AIDS) malignancies such as Kaposi's sarcoma and non-Hodgkin's lymphoma due to partial immune recovery and an increase in non-AIDS-defining malignancies due to prolonged survival. Management of HIV-infected patients with cancer requires a multidisciplinary approach, involving both oncologists and HIV physicians to optimally manage both diseases and drug interactions between anticancer and anti-HIV drugs. The French CANCERVIH group presents here a review and an experience of managing non-AIDS malignancies in HIV-infected individuals.Entities:
Keywords: AIDS; HIV; cancer; review; treatment
Mesh：
Year: 2015 PMID： 26681686 DOI： 10.1093/annonc/mdv606
Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976